Jingxin Pharm was established in 1974 and has been developed as one of the National Important High-tech Enterprises, Top 100 Pharmaceutical Enterprises and the Listed Company. The products covered from API to Finished Product, more than 160 products have been approved. It is one the biggest manufacturing base for the APIs of quinolones ,distributed to countries like South-east of Asia, South Asia, Latin America and Europe. All of its facilities have been approved by sFDA and ISO14001.Both of its API and formulations have been approved by the EU GMP, this can indicate its strong competitive ability.
